Abstract
Hematopoietic stem cell transplantation (HSCT) is one available curative treatment for sickle cell disease (SCD). The process of deciding in favor or against the procedure encompasses several factors, including the prospect of improving long-term quality of life (QoL). The present study aimed to assess the QoL indexes of adult patients with SCD who underwent allogeneic HSCT. In this descriptive, exploratory, cross-sectional study, patients were assessed before and at 1 and 2 years after transplantation, by the Generic Questionnaire for Quality of Life Assessment (SF-36). For each of the eight components of SF-36, the differences between assessments at each time point (pre-HSCT, 1 year, and 2 years) were compared. The population was composed of 14 patients (nine males) with a mean age of 28.07 years. The results showed significant increase in all eight components of the SF-36 in the three time points compared, evidencing that even long-term after the procedure, the QoL continues to increase. The physical components of SF-36 improved since the first year post-HSCT. Important variables for the preservation of QoL were detected: not having developed GVHD, being gainfully employed, and having more than 8 years of schooling. Importantly, there was also a delayed but significant increase in the mental component of SF-36, here shown as unprecedented data. These results reaffirm that it is worth investing in HSCT for sickle cell patients.
Similar content being viewed by others
Data Availability
The data sets generated during and/or analyzed during the ongoing study are not publicly available due to ethical issues but are available from the corresponding author upon reasonable request.
Code Availability
Not applicable.
References
Alves, R. C. P., Oliveira-Cardoso, E. A., Mastropietro, A. P., Voltarelli, J. C., & Santos, M. A. (2012). Transplante de células-tronco hematopoéticas e qualidade de vida após a alta hospitalar. Psicologia, Saúde & Doenças, 13(1), 87–99.
Arnold, S. D., Jin, Z., Sands, S., Bhatia, M., Kung, A. L., & Satwani, P. (2015). Allogenic hematopoietic cell transplantation for children with sickle cell disease is beneficial and cost-effective: A single-center analysis. Biology of Blood and Marrow Transplantation, 21(7), 1258–1265. https://doi.org/10.1016/j.bbmt.2015.01.010
Bhatia, M., Kolva, E., Cimini, L., Jin, Z., Satwani, P., Savone, M., George, D., Garvin, J., Paz, M. L., Briamonte, C., Cruz-Arrieta, E., & Sands, S. (2015). Health- related quality of life after allogenic hematopoietic stem cell transplantation for sickle cell disease. Biology of Blood and Marrow Transplantation, 21(4), 666–672. https://doi.org/10.1016/j.bbmt.2014.12.007
Cançado, R. D., Lobo, C., Angulo, I., Araújo, P. I. C., & Jesus, J. A. (2009). Protocolo clínico e diretrizes terapêuticas para uso de hidroxiureia na anemia falciforme. Revista Brasileira De Hematologia e Hemoterapia, 31(5), 361–366. https://doi.org/10.1590/S1516-84842009005000076
Cela, E., Vélez, A. G., Aguado, A., Medín, G., Bellón, J. M., & Beléndez, C. (2016). Chronic brain damage in sickle cell disease and its relation with quality of life. Medicina Clinica, 147(12), 531–536. https://doi.org/10.1016/j.medcle.2016.12.041
Ciconelli, M. R., Ferraz, B. M., Santos, W., Meinão, I., & Quaresma, R. M. (1999). Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF 36 (Brasil SF 36). Revista Brasileira De Reumatologia, 39(3), 209–214.
Crovador, L. F., Oliveira-Cardoso, E. A., Mastropietro, A. P., & Santos, M. A. (2013). Qualidade de vida relacionada à saúde de pacientes com esclerose múltipla antes do transplante de células-tronco hematopoéticas. Psicologia: Reflexão e Crítica, 26(1), 58–66. https://doi.org/10.1590/S0102-79722013000100007
Dias, V. N., Mastropietro, A. P., Oliveira-Cardoso, E. A., & De Carlo, M. M. R. P. (2012). Transplante de células-tronco hematopoéticas – Um estudo controlado sobre papéis ocupacionais. Caderno De Terapia Ocupacional UFSCAR, 20(2), 165–171. https://doi.org/10.4322/cto.2012.016
Ferrari, G., Cavazzana, M., & Mavilio, F. (2017). Gene therapy approaches to hemoglobinopathies. Hematology/oncology Clinics of North America, 31(5), 835–852. https://doi.org/10.1016/j.hoc.2017.06.010
Filipovich, A. H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J. R., Lee, S. J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E. W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J. D., … Flowers, M. E. (2005). National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology Blood Marrow Transplantation, 11(12), 945–56. https://doi.org/10.1016/j.bbmt.2005.09.004
Fredenburg, H. A., & Silverman, M. J. (2014). Effects of music therapy on positive and negative affect and pain with hospitalized patients recovering from a blood and marrow transplant: A randomized effectiveness study. The Arts in Psychotherapy, 41, 174–180. https://doi.org/10.1016/j.aip.2014.01.007
Gallo, A. M., Patil, C., Adeniyi, T., Hsu, L. L., Rondelli, D., & Saraf, S. (2018). Health-related quality of life and personal life goals of adults with sickle cell disease after hematopoietic stem cell transplantation. West Journal Research, 41(4), 555–575. https://doi.org/10.1177/0193945918768277
Gluckman, E., Cappelli, B., Bernaudin, F., Labopin, M., Volt, F., Carreras, J., Simões, B. P., Ferster, A., Dupont, S., de la Fuente, J., Dalle, J. H., Zecca, M., Walters, M. C., Krishnamurti, L., Bhatia, M., Leung, K., Yanik, G., Kurtzberg, J., Dhedin, N., … Eapen, M. (2017). Sickle cell disease: An international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood, 129(11), 1548–1556. https://doi.org/10.1182/blood-2016-10-745711
Goetzmann, L., Klaghofer, R., Wagner-Huber, R., Halter, J., Boehler, A., Muellhaupt, B., Schanz, U., & Buddeberg, C. (2006). Quality of life and psychosocial situation before and after a lung, liver or an allogeneic bone marrow transplantation. Swiss Medical Weekly, 136, 281–290.
Guimarães, F. A. B., Oliveira-Cardoso, E. A., Mastropietro, A. P., Voltarelli, J. C., & Santos, M. A. (2010). Impact of autologous hematopoetic stem cell transplantation on the quality of life of patients with multiple sclerosis. Arquivos De Neuro-Psiquiatria, 68(4), 522–527. https://doi.org/10.1590/S0004-282X2010000400009
Graves, J. K., Hodge, C., & Jacob, E. (2016). Depression, anxiety, and quality of life in children and adolescents with sickle cell disease. Pediatric Nursing, 42(3), 113–119.
Kanter, J., Liem, R. I., Bernaudin, F., Bolaños-Meade, J., Fitzhugh, C. D., Hankins, J. S., Murad, M. H., Panepinto, J. A., Rondelli, D., Shenoy, S., Wagner, J., Walters, M. C., Woolford, T., Meerpohl, J. J., & Tisdale, J. (2021). American Society of Hematology 2021 guidelines for sickle cell disease: Stem cell transplantation. Blood Advance, 5(18), 3668–3689.
Kelly, M. J., Pennarola, B. W., Rodday, A. M., & Pearsons, S. K. (2012). Health-related quality of life (HRQL) in children with sickle cell disease and thalassemia following hematopoietic stem cell transplant (HSCT). Pediatric Blood & Cancer, 59(4), 725–731. https://doi.org/10.1016/j.bbmt.2014.12.007
Khemani, K., Ross, D., Sinha, C., Haight, A., Bakshi, N., & Krishnamurti, L. (2018). Experiences and decision making in hematopoietic stem cell transplant in sickle cell disease: Patients’ and caregivers’ perspectives. Biology of Blood and Marrow Transplantation, 24(5), 1041–1048. https://doi.org/10.1016/j.bbmt.2017.11.018
Marques, A. C. B., Proença, S. F. F. S., Machado, C. A. M., Guimarães, P. R. B., Bettencourt, P. R., Maftum, M. A., & Kalinke, L. P. (2017). Qualidade de vida nos primeiros seis meses pós-transplante de células-tronco Hematopoéticas. Texto & Contexto-Enfermagem, 26(3), 5040016. https://doi.org/10.1590/0104-07072017005040016
Martins, P. R. J., Moraes-Souza, H., & Silveira, T. B. (2010). Morbimortalidade em doença falciforme. Revista Brasileira De Hematologia e Hemoterapia, 32(5), 378–383. https://doi.org/10.1590/S1516-84842010000500010
Mastropietro, A. P., Oliveira-Cardoso, E. A., Simões, B. P., Voltarelli, J. C., & Santos, M. A. (2010a). Impacto da DECH crônica na qualidade de vida pós-TCTH alogênico. Revista Brasileira De Hematologia e Hemoterapia, 32(5), 358–364. https://doi.org/10.1590/S1516-84842010000500007
Mastropietro, A. P., Oliveira-Cardoso, E. A., Simões, B. P., Voltarelli, J. C., & Santos, M. A. (2010b). Relação entre renda, trabalho e qualidade de vida de pacientes submetidos ao transplante de medula óssea. Revista Brasileira De Hematolologia e Hemoterapia, 32(2), 102–107. https://doi.org/10.1590/S1516-84842010005000035
Mastropietro, A. P., Oliveira-Cardoso, E. A., & Santos, M. A. (2011). Vida ocupacional de pacientes sobreviventes ao transplante de medula óssea: Estudo exploratório. Revista Brasileira De Orientação Profissional, 12(2), 241–252.
Menezes, A. S. O. P., Len, C. A., Hilário, M. O. E., Terreri, M. T. R. A., & Braga, J. A. P. (2013). Qualidade de vida em portadores de doença falciforme. Revista Paulista De Pediatria, 31(1), 24–29. https://doi.org/10.1590/S0103-05822013000100005
O’Brien, S. H. O., & Hankins, J. S. (2009). Decision analysis of treatment strategies in children with severe sickle cell disease. Journal of Pediatric Hematology/oncology, 31(11), 873–878. https://doi.org/10.1097/MPH.0b013e3181b83cab
Roth, M., Krystal, J., Manwani, D., Driscoll, C., & Ricafort, R. (2012). Stem cell transplant for children with sickle cell anemia: Parent and patient interest. Biology of Blood and Marrow Transplantation, 18(11), 1709–1715. https://doi.org/10.1016/j.bbmt.2012.05.013
Saraf, S. L., Oh, A. L., Patel, P. R., Jalundhwala, Y., Sweiss, K., Koshy, M., Campbell-Lee, S., Gowhari, M., Hassan, J., Peace, D., Quigley, J. G., Khan, I., Molokie, R. E., Hsu, L. L., Mahmud, N., Levinson, D. J., Pickard, A. S., Garcia, J. G., Gordeuk, V. R., & Rondelli, D. (2016). Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease. Biology of Blood and Marrow Transplantation, 22(3), 441–448. https://doi.org/10.1016/j.bbmt.2015.08.036
Silva, R. B. P., Ramalho, A. S., & Cassorla, R. M. S. (1993). A anemia falciforme como problema de Saúde Pública no Brasil. Revista De Saúde Pública, 27(1), 54–58.
Simões, B. P., Pieroni, F., Costa, T., Barros, G. N., Darrigo, G Jr., Grecco, C. S., Bernardes, J. E., Moraes, D., Stracieri, A. B. L., Cunha, R., & Rodrigues, M. C. (2016). Allogenic bone narrow transplantation in sickle-cell diseases. Revista da Associação Médica Brasileira, 62(1), 16–22. https://doi.org/10.1590/1806-9282.62.Suppl1.16
Sociè, G., Salloja, N., Cohen, A., Rovelli, A., Carreras, E., Locasciulli, A., Korthof, E., Weis, J., Levy, V., & Tichelli, A. (2003). Nonmalignant late effects after allogeneic stem cell transplantation. Blood, 101(9), 3373–3385. https://doi.org/10.1182/blood-2002-07-2231
Thomas, J. A., & Lipps, G. E. (2011). Subjective well-being of adults with homozygous sickle cell disease in Jamaica. Western Indian Medical Journal, 60(1), 181–187.
Toubai, T., Sun, Y., & Reddy, P. (2008). GVHD pathophysiology: Is acute different from chronic? Best Practice & Research Clinical Haematology, 21(2), 101–117. https://doi.org/10.1016/j.beha.2008.02.005
Funding
This research was funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES).
Author information
Authors and Affiliations
Contributions
Lucas dos Santos Loterio was the principal researcher, responsible for collecting data and preparing the manuscript, during his master’s degree. Érika Arantes de Oliveira-Cardoso was the researcher–advisor, contributing to the conduction of the research and preparing the manuscript. Belinda Pinto Simões and Maria Carolina de Oliveira were the heads of the departments where the research was conducted and allowed it to happen, as well as participating in the writing and revision of the manuscript. Juliana Tomé Garcia and Ana Luisa Guimarães assisted in data collection. Karla, Thalita, Renato, and Manoel participated in the revision of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval
The project was approved by the Research Ethics Committee of the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto (FFCLRP-USP), on an Ordinary Meeting, on August 24th, 2017, CAAE nº 72589517.7.0000.5407.
Consent to Participate
All participants agreed to participate voluntarily in the survey and signed written consent forms with the knowledge that they could leave the study at any time without any harm in their treatment.
Consent for Publication
The consent forms the participants signed also informed them that the data collected could be published for educational purposes.
Conflict of Interest
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
dos Santos Lotério, L., de Oliveira-Cardoso, É.A., Simões, B.P. et al. Quality of Life of Sickle Cell Disease Patients After Hematopoietic Stem Cell Transplantation: a Longitudinal Study. Trends in Psychol. 30, 513–527 (2022). https://doi.org/10.1007/s43076-021-00132-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43076-021-00132-9